Unilabs in the News

Unilabs SubHolding AB (publ) (the “Issuer”) today announced the offering of €130,000,000 aggregate principal amount of its existing 5.75% senior notes due 2025 (the “Notes”).

European medical diagnostics leader Unilabs announces today that Philipp Manser, the company’s CFO, has resigned for personal reasons.

Unilabs, Europe’s leading provider of clinical laboratory testing and medical diagnostic imaging services, reports a solid Q2 2017, delivering the 12th consecutive quarter of EBITDA growth.

Unilabs announced today an agreement to acquire Blufstein, one of the top 3 accredited and private laboratories in Peru, for an undisclosed amount.

Unilabs today announced it has signed a definitive agreement to acquire a share of Scientific Clinical Laboratories (SCL) for an undisclosed amount. Established in 1990, SCL has been providing highly-specialised laboratory services in the UAE, with a strong brand recognition and a leading market position.

Unilabs has today signed definitive ​agreement to acquire Base Holding, a leading diagnostic company in Portugal, which services customers in clinical analysis, radiology and cardiology. With this acquisition, Unilabs expands its portfolio of diagnostic services in Portugal to radiology and extends its presence in the country.

Geneva, Porto 19th June 2017. Geneva based Unilabs today announced that it has reached an agreement to acquire CGC Genetics, a leading Medical Genetics Laboratory company serving customers in more than 65 countries, for an undisclosed amount from private equity firm Vallis Capital Partners.

Unilabs SubHolding AB (publ) (the “Issuer”) today announced that it has priced its offering of €250,000,000 aggregate principal amount of 5.75% senior notes due 2025 (the “Notes”). The offering is expected to close on May 5, 2017.

European medical diagnostics leader Unilabs reports a strong start into to 2017, delivering the 11th consecutive quarter of EBITDA growth. Commenting on the results, Jos Lamers, Chief Executive Officer stated, “What makes this quarter particularly noteworthy is that we have generated strong growth across both our Lab and Imaging segments as well as our various regions. This is also our 11th consecutive quarter delivering a sustainable organic EBITDA growth.”

Geneva, Switzerland, based European medical diagnostics leader Unilabs has completed the acquisition of Alpha Medical group from private equity firm Mid Europa Partners for an undisclosed amount. This follows the announcement of the agreement on February 9th, 2017.

Geneva based Unilabs today announced that it has reached an agreement to acquire Alpha Medical, a leading medical diagnostics company serving customers in Slovakia and the Czech Republic, from private equity firm Mid Europa Partners for an undisclosed amount.